MAX M. PEET, M.D.; EMIL M. ISBERG, M.D., Assoc.
This content is PDF only. Please click on the PDF icon to access.
Much too frequently the clinician's interest in the problem of malignant hypertension has been one of diagnostic curiosity only. He has accepted both a hopeless prognosis and his personal inadequacy to cope with this dreadful disease. So he concerns himself with the problem of differential diagnosis, follows his patient to the autopsy room, and then takes pride in his capability for having differentiated this disease from terminal glomerulonephritis.
It is indeed important that the clinical entity of malignant hypertension be recognized. Diagnosis must be reached without temporization. However, once the diagnosis is made, arrangements for treatment by splanchnic resection should
PEET MM, ISBERG EM. THE PROBLEM OF MALIGNANT HYPERTENSION AND ITS TREATMENT BY SPLANCHNIC RESECTION1. Ann Intern Med. ;28:755–767. doi: 10.7326/0003-4819-28-4-755
Download citation file:
Published: Ann Intern Med. 1948;28(4):755-767.
Cardiology, Coronary Risk Factors, Hypertension, Nephrology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use